FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to dermatology, and aims at treating patients with morphea guttata. For treating morphea guttata, tacrolimus ointment (Tacropic) 0.1 % is applied externally with simultaneous administration of immunomodulating azoximer bromide (polyoxidonium) preparation in the form of rectal suppositories No.6, daily, in course of 14 days.;EFFECT: use of the invention provides higher clinical effectiveness in plaque scleroderma, reduces side effects, more quickly achieves a positive effect and prolonged clinical remission.;1 cl, 1 tbl, 2 ex
展开▼
机译：技术领域本发明涉及医学，即皮肤病学，其目的是治疗患有吗啡胶的患者。为了治疗牙龈炎，每天使用他克莫司软膏（Tacropic）0.1％，同时以14号直肠栓剂的形式每天以6号直肠栓剂的形式给予免疫调节性偶氮基溴化物（polyoxidonium）制剂;效果：使用本发明在斑块硬皮病中具有更高的临床疗效，减少了副作用，更快地达到了肯定的效果并延长了临床缓解期。1cl，1 tbl，2 ex
展开▼
